Oppenheimer analyst Francois Brisebois maintained a Buy rating on Simulations Plus (NASDAQ:SLP) on Tuesday, setting a price target of $79, which is approximately 16.23% above the present share price of $67.97.
Brisebois expects Simulations Plus to post earnings per share (EPS) of $0.17 for the fourth quarter of 2020.
The current consensus among 2 TipRanks analysts is for a Moderate Buy rating of shares in Simulations Plus, with an average price target of $87.
The analysts price targets range from a high of $95 to a low of $79.
In its latest earnings report, released on 05/31/2020, the company reported a quarterly revenue of $12.3 million and a net profit of $3.86 million. The company's market cap is $1.35 billion.
According to TipRanks.com, Oppenheimer analyst Francois Brisebois is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 6.9% and a 46.77% success rate.
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.